10.10.2019 12:00Seminar on Digital Health & Intellectual Property by Katzarov
In healthcare/pharmaceuticals, the arising of digital technologies opens a new area of protectable innovations along with drugs derived from biotechnologies or synthetic chemistry.
These innovations are nowadays based on digital technologies comprising new mathematical solutions such as algorithms or neural networks which process a vast amount of data (Big Data) using the increased computing power available.
The implications of these digital technologies for personalized medicine, identification of new biomarkers, methods for predicting the likelihood of a disease or diagnosing a disease based on newly identified biomarkers to name a few are considerable and require thorough thinking/planning when it comes to protecting intellectual property.
As a matter of fact, many aspects of digital technologies are protectable by filing patents/patents applications, design applications, trademarks and domain names.
- Julie Mondon – Trademark & Design Attorney
- Matthias Kügele – European Patent & Design Attorney
- Antoine Dieudonné-Vatran – European Patent Attorney